Key Takeaways
- Marvell Technology (MRVL) posted record Q2 revenue of $2.74 billion, beating estimates and raising its Q3 outlook on the back of a 46% year-over-year surge in data center revenue.
- Gap Inc. (GAP) announced that CEO Richard Dickson will transition to an advisory role, with Francis (Michael Francis) succeeding him, as the company reported mixed Q2 results with a 10% rise in global comparable sales.
- Autodesk (ADSK) raised its full-year revenue guidance to a range of $8.30 billion to $8.35 billion after exceeding Q2 expectations with $2.05 billion in revenue.
- Moderna (MRNA) received FDA approval for its updated 2026-2027 COVID-19 vaccines, including the new mNEXSPIKE formula, targeting the JN.1-lineage XFG subvariant.
- Wall Street finished higher on Thursday, led by a 1.56% gain in the Nasdaq Composite, as strong technology earnings from companies like Nvidia (NVDA) and Marvell buoyed investor sentiment.
Tech Earnings and Market Performance
The Nasdaq Composite unofficially ended the session higher by 407.44 points, or 1.56%, finishing at 26,537.63. This rally was largely driven by robust performance in the semiconductor and software sectors. The S&P 500 rose 0.72% to 7,731.33, while the Dow Jones Industrial Average saw a more modest gain of 0.21%, closing at 53,578.73.
Marvell Technology (MRVL) reported a standout second quarter, with adjusted EPS of 94 cents on revenue of $2.74 billion, both exceeding analyst expectations. The company’s data center segment now accounts for 79% of total revenue, reflecting the massive demand for AI infrastructure. For the third quarter, Marvell expects adjusted EPS between $1.05 and $1.15 and revenue of approximately $3.15 billion.
Autodesk (ADSK) also contributed to the tech sector's momentum, posting Q2 revenue of $2.05 billion against the $2.01 billion estimate. Despite raising its full-year revenue outlook, the company's stock saw some after-hours pressure as its full-year EPS guidance of $12.52 to $12.60 fell slightly short of the consensus midpoint.
Retail and Leadership Shifts at Gap
Gap Inc. (GAP) made waves with the announcement of a leadership transition. Richard Dickson will move to an advisory role, making way for Francis to take over as CEO. The leadership change comes as the company navigates a complex retail environment; while Gap brand comparable sales rose in the double digits, Old Navy comparable sales fell 4%, leading to a total comparable sales decline of 1%.
Financially, Gap reported Q2 net sales of $3.65 billion, missing the $3.69 billion estimate. However, the company showed resilience in profitability, posting an adjusted EPS of 52 cents, which beat the 50-cent estimate, and a gross margin of 41.4%. The company issued a positive outlook for Q3, projecting net sales growth of 1.5% to 2.5%.
Healthcare and Automotive Developments
In the healthcare sector, Moderna (MRNA) announced that the FDA has approved its updated 2026-2027 COVID-19 vaccines. The approval covers both Spikevax and the new mNEXSPIKE formula, which are designed to combat the latest circulating variants. These vaccines are expected to be available to the public in the coming days, ahead of the fall respiratory virus season.
In the automotive industry, Toyota (TM) is reportedly accelerating its production of next-generation electric vehicles (EVs) in China. According to Nikkei, the move is aimed at capturing cutting-edge technology in the world's largest EV market. This strategy highlights Toyota's effort to remain competitive against local Chinese manufacturers who have rapidly gained market share through advanced battery and software integration.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.